Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Xenetic Biosciences Cash Position $14.9M

Xenetic Biosciences Cash Position $14.9M

Xenetic Biosciences (NASDAQ:XBIO) will report on Q2 2022.

August 12, 2022

1 minute read

Xenetic Biosciences (NASDAQ:XBIO) will report on Q2 2022.

Citigroup Maintains Neutral on Outbrain, Raises Price Target to $5.3

February 6, 9:44 AM

Citigroup analyst Ygal Arounian maintains Outbrain (NASDAQ:OB) with a Neutral and raises the price target from $4 to $5.3.

September 1, 7:41 AM

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.

July 6, 8:18 AM

Maxim Group analyst Anthony Vendetti initiates coverage on Aclarion (NASDAQ:ACON) with a Buy rating and announces Price Target of $3.

July 20, 5:53 AM

Evercore ISI Group analyst John Pancari downgrades Ally Financial (NYSE:ALLY) from Outperform to In-Line and announces $36 price target.